Altogether, these results show that SOX2, ALDH1A1 and ALDH1A3 expression, together with their associated ALDEFLUOR activities are progressively enhanced in CSC subpopulations during sarcoma progression toward more aggressive phenotypes. Here, SOX2 is linked to sarcoma.